Negative HBcAg in immunohistochemistry assay of liver biopsy is a predictive factor for the treatment of patients with nucleos(t)ide analogue therapy

The hepatitis B core antigen (HBcAg) is an important target for antiviral response in chronic hepatitis B (CHB) patients. However, the correlation between HBcAg in the hepatocyte nucleus and nucleos(t)ide analogue (NA) therapeutic response is unclear. We sought to evaluate the role of HBcAg by analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Mingxing, Liu, Jian, Chow, Monica, Zhou, Xuan, Han, Zongping, He, Zhenjian, Xue, Jinfang, Zhu, Zhe, Li, Xinhua, Xia, Jinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824392/
https://www.ncbi.nlm.nih.gov/pubmed/29193766
http://dx.doi.org/10.1111/jcmm.13444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824392/
https://www.ncbi.nlm.nih.gov/pubmed/29193766
http://dx.doi.org/10.1111/jcmm.13444

Ejemplares similares